难治性高血压对2型糖尿病患者的预后重要性:里约热内卢2型糖尿病队列研究
该队列研究纳入646例2型糖尿病患者,依据随访第一年诊室血压诊断表观难治性高血压,并用24小时动态血压监测区分为白大衣/控制性难治性高血压和真性/未控制性难治性高血压。中位随访10年发现,表观难治性高血压预测心血管事件和死亡风险增加,真性难治性高血压还预测肾脏结局,动态血压监测分类可改善风险分层。
要点
- 表观难治性高血压增加2型糖尿病患者的总体心血管事件和死亡风险。
- 真性难治性高血压进一步增加风险,并额外预测肾脏结局。
- 动态血压监测分类有助于改善心血管和死亡风险分层。
核心结论
- 在2型糖尿病患者中,表观难治性高血压与心血管事件及死亡风险增加相关。
- 基于动态血压监测的分类可预测肾脏结局并改善心血管/死亡风险分层。
研究设计与样本
- 里约热内卢2型糖尿病队列研究,共646例患者。
- 根据随访第一年平均诊室血压诊断表观难治性高血压,并用24小时动态血压监测区分为白大衣/控制性或真性/未控制性难治性高血压。
- 采用多变量Cox分析评估难治性高血压诊断与微血管、心血管并发症及全因和心血管死亡的关系。
主要发现
- 中位随访10年,177例发生心血管事件(145例主要事件),222例死亡(101例心血管死亡),200例肾脏事件,156例视网膜病变事件,174例神经病变事件。
- 相对于非难治性高血压个体,表观难治性高血压预测所有心血管和死亡结局,风险比(HR)在1.64至2.16之间,但不预测微血管结局。
- 真性难治性高血压使HR升高(从1.81至2.25),并额外预测肾脏结局。
- 白大衣/控制性难治性高血压风险增加(HR 1.33-1.86),介于非难治性高血压和真性难治性高血压之间。
关键数值与推荐
- 表观难治性高血压诊断基于随访第一年平均诊室血压。
- 动态血压监测分类使用传统血压切点和2017年ACC/AHA标准。
临床怎么用
- 对2型糖尿病合并难治性高血压患者,应考虑动态血压监测以区分白大衣/控制性 vs 真性/未控制性难治性高血压。
- 动态血压监测分类有助于识别肾脏结局高风险患者并改善心血管/死亡风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the prognostic importance of resistant hypertension (RHT) for the development of complications in a cohort of individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 646 patients had the diagnosis of apparent treatment-resistant hypertension (aRHT) based on mean office blood pressure (BP) levels during the 1st year of follow-up. They were reclassified as white-coat/controlled or true/uncontrolled RHT according to 24-h ambulatory BP monitoring (ABPM), using the traditional BP cutoffs and the new 2017 American College of Cardiology (ACC)/American Heart Association (AHA) criteria. Multivariate Cox analyses examined the associations between RHT diagnoses and the occurrence of microvascular and cardiovascular complications and all-cause and cardiovascular mortality. RESULTS: During a median follow-up of 10 years, 177 patients had a cardiovascular event (145 major ones); 222 patients died (101 from cardiovascular diseases); 200 had a renal event; 156 had a retinopathy event; and 174 patients had a neuropathy event. In relation to non-RHT individuals, aRHT (present in 44.6% and 50% by the traditional and new criteria, respectively) predicted all cardiovascular and mortality outcomes, with hazard ratios (HRs) between 1.64 and 2.16, but none of the microvascular outcomes. True RHT increased the HRs (from 1.81 to 2.25) and additionally predicted renal outcomes. White-coat/controlled RHT implied an increased risk (HRs 1.33-1.86) that was intermediate between non-RHT and true RHT individuals. Classifications using the traditional and the new ACC/AHA criteria were equivalent. CONCLUSIONS: In patients with type 2 diabetes, the presence of aRHT implied an increased risk of cardiovascular and mortality outcomes, and classification based on ABPM predicted renal outcomes and improved cardiovascular/mortality risk stratification.
引用
- Cardoso CRL, Leite NC, Bacan G, et al. Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetes Care. 2019. PMID: 31619394. doi:10.2337/dc19-1534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。